1 Angiotensin II AT 2 receptor inhibits smooth muscle cell migration via fibronectin cell production and binding CATHERINE CHASSAGNE, 1,➊,* CHRISTOPHE ADAMY, 1,➊ PHILIPPE RATAJCZAK, 1 BRUNO GINGRAS, 2 EMMANUEL TEIGER, 3 EMMANUELLE PLANUS, 3 PATRICIA OLIVIERO, 1 LYDIE RAPPAPORT, 1 JANE-LISE SAMUEL, 1 AND SYLVAIN MELOCHE 2 . 1 INSERM U127, Institut Fédératif de Recherche Circulation Paris VII, Hôpital Lariboisière, Université Denis Diderot, Paris, France. 2 Institut de Recherches Cliniques de Montréal, avenue des Pins Ouest, Montréal (Qc), Canada. 3 INSERM U492, Institut de Médecine Moléculaire, Hôpital Henri-Mondor, Créteil, France. ➊ Equal contribution of the authors. Running title: AT 2 receptor and smooth muscle cell migration * Address correspondence to Catherine Chassagne, INSERM U 127, Hôpital Lariboisière, 41 bvd de la Chapelle, 75475 Paris cedex 10, Paris, France. Tel: 33 144 631 742. Fax: 33 148 742 315. E-mail: catherine.chassagne@inserm.lrb.ap-hop-paris.fr Abbreviations used in this paper: vascular smooth muscle cell (SMC); angiotensin II (Ang II); extracellular matrix (ECM); fibronectin (FN) and laminin (LAM) substrates; cellular fibronectin (c-Fn); cytoskeleton (CSK). Previously presented in part at the 74th Scientific Sessions of the American Heart Association, Anaheim, Ca., November 11-14, 2001. Copyright 2001 by the American Physiological Society. AJP-Cell Articles in PresS. Published on November 27, 2001 as DOI 10.1152/ajpcell.00318.2001